These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9146474)

  • 1. Tuberculosis. Part II.
    LoBue PA; Catanzaro A; Dutt AK; Stead W
    Dis Mon; 1997 Apr; 43(4):181-274. PubMed ID: 9146474
    [No Abstract]   [Full Text] [Related]  

  • 2. Microscopic observation drug susceptibility (MODS): where are we going?
    Kam KM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):127. PubMed ID: 24429301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multidrug-resistant tuberculosis in Romania].
    Stoicescu IP; Didilescu C; Bercea O
    Pneumoftiziologia; 1997; 46(3):161-78. PubMed ID: 9654954
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistant plus susceptible tuberculosis: the undiscovered country.
    Ahmad Khan F; Behr M
    J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis].
    Botelho-Nevers E
    Med Mal Infect; 2015; 45(1-2):61-2. PubMed ID: 25893234
    [No Abstract]   [Full Text] [Related]  

  • 6. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Usefulness of studies on antitubercular drug resistance].
    Valenzuela P
    Rev Panam Salud Publica; 1997 Jan; 1(1):62-7. PubMed ID: 9162582
    [No Abstract]   [Full Text] [Related]  

  • 8. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Multidrug-resistant Tuberculosis Infection in Children.
    Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
    Pediatr Infect Dis J; 2018 Aug; 37(8):831-834. PubMed ID: 29742640
    [No Abstract]   [Full Text] [Related]  

  • 10. Why is long-term therapy required to cure tuberculosis?
    Connolly LE; Edelstein PH; Ramakrishnan L
    PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 12. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 13. Treat the patient, not the result.
    Padayatchi N; Quantrill J
    S Afr Med J; 2009 Jun; 99(6):412. PubMed ID: 19736836
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired drug resistance: we can do more than we think!
    Alffenaar JW; Gumbo T; Aarnoutse RE
    Clin Infect Dis; 2015 Mar; 60(6):969-70. PubMed ID: 25527653
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis.
    Bernard C; Brossier F; Fréchet-Jachym M; Morand PC; Coignard S; Aslangul E; Aubry A; Jarlier V; Sougakoff W; Veziris N
    Emerg Infect Dis; 2014 Mar; 20(3):506-7. PubMed ID: 24565423
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
    Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
    [No Abstract]   [Full Text] [Related]  

  • 18. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 19. Pakistan's battle with multi-drug resistant tuberculosis--establishing the ground rules.
    Saleem T; Khalid U
    J Pak Med Assoc; 2012 Jan; 62(1):80. PubMed ID: 22352115
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis susceptibility--implications for drug development and therapy.
    Snell NJ
    Expert Opin Pharmacother; 2003 Sep; 4(9):1455-60. PubMed ID: 12943474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.